Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Denver-Aurora, CO MSA — September 2026
Denver regulatory pay softens as clinical trial talent tightens.
Metro Regulatory Affairs Specialist pay fell to $97,512 against a national $104,000 median, while Clinical Research Associate pay climbed to $97,530 — reversing the usual metro discount amid 3.9% Denver unemployment.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Denver-Aurora unemployment rate: 3.9% — vs 4.1% national rate, mid-2026
- Colorado job growth, 2026 projected: 0.6% — 17,500 jobs, 3rd month of state losses
- Regulatory Affairs Specialist pay, metro: $97,512 — down significantly, below $104,000 national
- Clinical Research Associate pay, metro: $97,530 — up significantly, above $90,956 national
Key takeaways
Regulatory affairs pay is softening locally against national scarcity.
Metro Regulatory Affairs Specialist pay dropped to $97,512, a significant decline that now sits below the $104,000 national median even as senior regulatory leadership commands six-figure premiums nationally. This divergence may signal Denver employers normalizing mid-level regulatory pay while the real scarcity concentrates at VP and director levels.
CRA compensation reversed the usual metro discount.
Denver's $97,530 median for Clinical Research Associates now exceeds the $90,956 national figure, an unusual inversion that is consistent with intensifying local clinical trial activity competing for a thin pipeline of experienced CRAs. Organizations building out clinical operations headcount should expect this premium to persist rather than treat it as a one-month anomaly.
Manufacturing build-out signals a bet against CDMO dependency.
The Colorado BioScience Institute's projection of 218-plus entry-level manufacturing openings across 13 employers points toward regional employers favoring in-house bioprocess capacity over outsourcing, even as national CMC director pay climbs to $220K-$520K. Metro Validation Engineer pay rising moderately to $111,831 supports this reading — build strategies are being funded, not just discussed.
Tight labor supply narrows who gets hired, not just how much they cost.
Colorado's 0.6% projected job growth alongside sub-4% metro unemployment means generalist and administrative roles face less pressure than specialized clinical, regulatory, and bioprocess positions. Headcount plans built around broad hiring volume may need re-weighting toward mission-critical specialist roles rather than proportional growth across functions.
Median advertised pay by role — Denver-Aurora, CO MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $95,000 | $116,119 | $150,000 | Significant increase | $131,354 |
| Clinical Research Associate | $70,750 | $97,530 | $103,620 | Significant increase | $90,956 |
| Lab Technician | $43,134 | $49,712 | $52,000 | Moderate increase | $47,402 |
| Regulatory Affairs Specialist | $73,600 | $97,512 | $116,373 | Significant decline | $104,000 |
| Clinical Data Manager | $99,278 | $125,073 | $142,800 | Moderate decline | $123,031 |
| Biostatistician | $111,379 | $131,943 | $158,127 | Moderate increase | $133,322 |
| Validation Engineer | $97,703 | $111,831 | $155,517 | Moderate increase | $108,377 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Denver-Aurora's unemployment rate held near 3.9% through mid-2026 even as Colorado posted its third straight month of statewide job losses, leaving the metro meaningfully tighter than the 4.1% national rate and signaling that life sci employers compete in a labor pool more constrained than headline state figures suggest. Median annual pay growth of 5.8% across Denver-Aurora-Lakewood, paired with Denver's minimum wage climbing to $19.29/hour, is compressing pay differentials between entry-level and specialized roles and forcing recalibration of internal pay bands.
What it means
Regulatory Affairs Specialist advertised pay fell to a metro median of $97,512 — down significantly and now trailing the $104,000 national figure — even as national VP-level regulatory compensation holds at $320K-$580K, suggesting Denver's regulatory talent pool is bifurcating between scarce senior leadership and a softening mid-career segment that may ease some hiring pressure. Clinical Research Associate pay, by contrast, climbed to $97,530 locally against a $90,956 national median, a reversal of the usual metro discount that points to acute local competition for clinical operations talent likely tied to GLP-1 and biotech clinical trial expansion. Consider reviewing regulatory affairs compensation bands against the current downward local trend before assuming parity with national scarcity narratives, while treating CRA retention as a nearer-term pressure point.
Looking ahead
Expected: Colorado's statewide job losses for July-August concentrated in professional/business services and information — sectors adjacent to life sci's administrative and data functions. Watch whether displaced talent from those sectors begins filling clinical data and biostatistics pipelines, which currently show declining to moderate pay pressure.
Worth watching: National September layoffs at BioMarin and Bristol Myers reflect consolidation rather than broad retrenchment, with 64% of surveyed biopharma organizations still actively recruiting. Monitor whether any Denver-based sites appear in forthcoming WARN filings, given Colorado's 2026 WARN volume is already down 11% year over year.
Emerging pressure point: Regulatory Affairs Specialist pay's significant local decline could reflect a genuine talent surplus or a temporary lag in advertised rates catching up to demand. Leaders should track whether open regulatory requisitions sit longer than usual before concluding the role has truly softened.
Potential inflection point: Colorado BioScience Institute's manufacturing hiring push lands directly into a labor market with just 0.6% projected statewide job growth. Watch whether the 218 projected manufacturing openings get filled on schedule or whether they stall, which would be an early signal that build-vs-outsource math needs revisiting.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.